Compounding of Hazardous Drugs

VTH Policy: PharmH651

Implementation Date: 11/2021

Date of Last Revision: 6/24/2023

Next Review Due: 6/23/2026

 

Reviewed by VTH Administrative Team: 11/2021

Reviewed by VTH Board: N/A

 

Reviewed & Approved by Hospital Director: 11/2021

Reviewed by Biosecurity Subcommittee: N/A

Subject to modification by the VTH Director without approval.

Policy

This policy intends to provide the procedure for compounding sterile and non-sterile hazardous drugs and chemicals (which may include chemotherapy, antiviral drugs, hormone therapy, some bioengineered drugs, and miscellaneous). This policy applies to healthcare personnel approved for the compounding of hazardous drugs.

Entity and personnel involved in compounding hazardous drugs must be compliant with appropriate USP standards for compounding, including USP 795, USP 797, and USP 800, as well as any applicable draft guidance for industry or compliance policy guides that are released.

Guidelines

  1. Compounding must be done within proper engineering controls.
  2. Disposable or cleaning equipment for compounding must be dedicated for use with HDs (such as mortars & pestles, counting trays, and spatulas) and be cleaned accordingly.
  3. Appropriate PPE must be worn when handling and compounding according to activity.

Procedure (if applicable)

  1. When manipulating hazardous drugs, such as cutting or crushing tablets or opening a capsule, appropriate PPE must be donned and protective measures must be used in order to contain and protect from any dust or particles generated.
  2. Compounding non-sterile hazardous drugs will be done in the non-sterile compounding room with required PPE (N95 and gloves). Non-sterile compounded hazardous drugs prepared in the Dispensary include the following: Tylosin capsules, Sotalol capsules, Sotalol oral suspension, and Mycophenolate oral suspension. In the VTH Dispensary, we do not compound non-sterile HDs from bulk chemicals or Class 1 HDs.
  3. A sink and eyewash station is available for emergency access to water for the removal of hazardous substances from skin and eyes. A shower is also available for spills of larger amounts.
  4. When compounding sterile hazardous drug preparations in a C-PEC, a plastic-backed preparation mat should be placed on the work surface of the C-PEC. The mat should be changed immediately if a spill occurs, or every 30 minutes during use, and should be discarded at the end of the activity. For appropriate PPE based on the activity, follow the chart below.

HD Formulation

Activity

Double chemotherapy gloves

Protective gown

 Eye/face protection

 Respiratory protection

Ventilated engineering control

Intact tablet or capsule

Administration from unit-dose package

*single glove can be used, unless spills occur*

 No

 No

 No

N/A

Tablets or capsules

Cutting, crushing or

manipulating tablets or capsules; handling uncoated tablets

YES

Yes

 No

Yes, if not in a control device

Yes, if possible

Administration

No *single glove can be used, unless spills occur*

  No

Yes, if potential vomiting

  No

N/A

Oral liquid drug or feeding tube

Compounding

YES

YES

Yes, if not in a control device

Yes, if not in a control device

YES

Administration

YES

YES

Yes, if potential vomiting

 No

N/A

Topical drug

Administration

YES

yes

 Yes, if potential splashing

 Yes, if inhalation potential

N/A

SQ/IM injection from vial

Preparation (withdrawal from vial)

YES

YES

Yes, if not in a control device

Yes, if not in a control device

YES, BSC OR CACI

Administration from prepared syringe

YES

Yes

Yes, if potential splashing

 No

N/A

Withdrawing/ mixing IV / IM solution from vial or ampule

Compounding

YES

YES

  No

 
 No

Yes, BSC or CACI; use of CSTD recommended

Administration from prepared solution

YES

YES

Yes, if potential splashing

  No

N/A; CSTD if dosage form allows

Solution for irrigation

Administration

YES

yes

yes

yes

N/A

Powder/ aerosol treatment / solution for inhalation

Aerosol administration

YES

YES

YES

YES

N/A

Administration

YES

YES

Yes, if potential splashing

Yes, if inhalation potential

N/A

Spills

Cleaning

YES

YES

YES

YES

N/A

Drug-contaminated waste

Disposal and cleaning

YES

YES

 Yes, if potential splashing

 Yes, if inhalation potential

N/A

Drugs and metabolites in body fluids

Disposal and cleaning

YES

YES

 Yes, if potential splashing

 Yes, if inhalation potential

N/A

Definitions (if applicable)

  • CTSD : Closed System Transfer Device
    • Drug transfer device that mechanically prohibits the transfer of environmental contaminants into the system and the escape of HD or vapor concentrations outside the system
  • PPE : Personal Protective Equipment
  • USP : United States Pharmacopeia
  • BSC : Biological Safety Cabinet
  • C-PEC : Containment Primary Engineering Control
  • CACI : Compounding Aseptic Containment Isolator
  • HD : Hazardous Drug

Veterinary Teaching Hospital (VTH): The collective clinical services of the Large Animal Clinic, Midwest Equine, the Small Animal Clinic, and the Veterinary Medicine South Clinic.



Keywordshazardous drugs, CSTD, Equashield, cleanroom   Doc ID129569
OwnerJenny C.GroupUofI College of Veterinary Medicine Teaching Hospital
Created2023-07-06 10:58 CDTUpdated2023-07-06 11:08 CDT
SitesUniversity of Illinois College of Veterinary Medicine Teaching Hospital
Feedback  0   0